MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

Search

Dynavax Technologies Corp

Cerrado

SectorSalud

10.47 1.85

Resumen

Variación precio

24h

Actual

Mínimo

10.02

Máximo

10.48

Métricas clave

By Trading Economics

Ingresos

-11M

7.1M

Ventas

-8.6M

72M

P/B

Media del Sector

57.05

59.668

BPA

0.05

Margen de beneficio

9.787

Empleados

405

EBITDA

2.2M

12M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+140.06% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-300M

1.4B

Apertura anterior

8.62

Cierre anterior

10.47

Noticias sobre sentimiento de mercado

By Acuity

42%

58%

125 / 385 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Dynavax Technologies Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

19 abr 2025, 01:45 UTC

Ganancias

Preview -- Barron's

18 abr 2025, 15:57 UTC

Principales Movimientos del Mercado

Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch

20 abr 2025, 22:32 UTC

Principales Noticias

Stocks Poised for Lower Open -- Barrons.com

20 abr 2025, 18:43 UTC

Principales Noticias

Chicago Fed's Goolsbee Has a Warning About Independence -- Barrons.com

20 abr 2025, 18:00 UTC

Principales Noticias

Tesla, Alphabet, Verizon, Chipotle, IBM, Boeing, and Many More Stocks to Watch This Week -- Barrons.com

20 abr 2025, 13:00 UTC

Principales Noticias

Airbus Promised a Green Aircraft. That Bet Is Now Unraveling. -- WSJ

20 abr 2025, 06:00 UTC

Principales Noticias

Foreign Stocks Are Beating the U.S. Market. Here's How Much You Should Have in Your Portfolio. -- Barrons.com

20 abr 2025, 03:00 UTC

Principales Noticias

Putin's War Economy Can't Escape Trump's Trade Blitz -- WSJ

20 abr 2025, 02:00 UTC

Principales Noticias

Who Will Pay the Price for Trump's Economic Goals? -- WSJ

19 abr 2025, 02:00 UTC

Principales Noticias

Tomatoes Become One of the First Everyday Casualties of Trade War -- WSJ

19 abr 2025, 02:00 UTC

Principales Noticias

Beijing Stokes Patriotic Fervor and Blames U.S. for Trade War -- WSJ

18 abr 2025, 20:42 UTC

Adquisiciones, fusiones, absorciones

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 abr 2025, 20:32 UTC

Principales Noticias

Trump to Replace Acting IRS Commissioner -- 2nd Update

18 abr 2025, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

18 abr 2025, 19:52 UTC

Charlas de Mercado

Correction to Aluminum Fee Rising Slower Than Forecast Article

18 abr 2025, 19:40 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

18 abr 2025, 19:40 UTC

Charlas de Mercado

Aluminum Fee Rising Slower Than Forecast From Tariff -- Market Talk

18 abr 2025, 18:51 UTC

Ganancias

Netflix Has Made Several Risky Bets. Earnings Show They've Paid Off. -- Barrons.com

18 abr 2025, 18:40 UTC

Adquisiciones, fusiones, absorciones

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 abr 2025, 18:29 UTC

Charlas de Mercado

Shorter Duration Seen as Way to Shield Portfolio From Political Turbulence -- Market Talk

18 abr 2025, 18:21 UTC

Principales Noticias

Ford Halts Shipments of F-150s and Other Models to China -- WSJ

18 abr 2025, 17:31 UTC

Principales Noticias

Trump to Replace Acting IRS Commissioner -- WSJ

18 abr 2025, 17:24 UTC

Adquisiciones, fusiones, absorciones

Capital One's Discover Takeover Gets the Green Light. The Two Will Create the 6th-Largest U.S. Bank. -- Barrons.com

18 abr 2025, 17:22 UTC

Adquisiciones, fusiones, absorciones

Capital One's $35 Billion Discover Takeover Clears Final Approvals -- Barrons.com

18 abr 2025, 16:00 UTC

Principales Noticias

Trump's Trade War Threatens One of America's Top Energy Exports -- WSJ

18 abr 2025, 15:53 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Bill Ackman Teases Prospect of Uber, Hertz Partnership -- Update

18 abr 2025, 15:46 UTC

Ganancias

Tech's Problems in China Are Getting Worse. These Companies Are Most at Risk. -- Barrons.com

18 abr 2025, 15:10 UTC

Charlas de Mercado
Ganancias

Netflix Momentum Likely To Continue Thanks To Growing Subscriber Base -- Market Talk

18 abr 2025, 14:46 UTC

Ganancias

Tech Earnings Have Good News for Chip Stocks, So Far. And 1 Warning. -- Barrons.com

18 abr 2025, 14:24 UTC

Charlas de Mercado
Ganancias

Netflix Still Has Room to Add Subscribers -- Market Talk

Comparación entre iguales

Cambio de precio

Dynavax Technologies Corp Esperado

Precio Objetivo

By TipRanks

140.06% repunte

Estimación a 12 meses

Media 24.75 USD  140.06%

Máximo 33 USD

Mínimo 10 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Dynavax Technologies Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

4

Comprar

0

Mantener

1

Vender

Puntuación técnica

By Trading Central

10.255 / 11.45Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Very Strong Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

125 / 385 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.